Jeffrey Weber, MD, PhD, discusses the unmet needs professionals take into consideration when deciding treatment options for patients with melanoma.
Jeffrey Weber, MD, PhD
Advertisement
Articles by Jeffrey Weber, MD, PhD
Medicial oncologist and melanoma expert Dr. Jeffrey Weber discusses the role of adjuvant immunotherapy in the setting of stage III melanoma.
Advertisement
Latest Updated Articles
Jeffrey Weber, MD, PhD, Describes Unmet Needs for Patients with MelanomaPublished: November 14th 2020 | Updated:
Adjuvant Immunotherapy in Advanced MelanomaPublished: March 22nd 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma
2
HDP-101 Receives FDA Fast Track Designation in Multiple Myeloma
3
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
4
Collagen Implant May Improve Local Control of Metastatic Brain Tumors
5
